Literature DB >> 23119115

Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report.

Eunice Choi1, Annisa L Lewis, Hidehiro Takei, Jae Y Ro.   

Abstract

Signet ring cell (SRC) features are rare but well-recognized cytological changes of pulmonary adenocarcinoma (PA). PA with SRC features (PA-SRC) is frequently associated with anaplastic lymphoma kinase (ALK) gene rearrangement, and recognition of PA-SRC may be important for the administration of targeted treatment. To the authors' knowledge, leptomeningeal carcinomatosis (LMC) as an initial presentation of PA-SRC has not yet been reported. We report an autopsy case from a 59-year-old female who presented with intractable headache for 6 weeks and died of LMC as a result of metastatic PA-SRC. Premortem brain MRI showed nonspecific leptomeningeal enhancement. At autopsy, a tan rubbery mass was found in the hilar area of the right lung, which also surrounded the lower trachea and carotid arteries. A right posteromedial middle lobe mass was also found. Leptomeninges were slightly thickened, without discrete masses. Microscopic examination of the lung mass and leptomeninges showed solid sheets and nests of malignant cells with pleomorphic nuclei and frequent SRC features which comprised 50% of the mass. Immunohistochemically, the tumor cells demonstrated strong diffuse expression of cytokeratin (CK)-7, TTF-1, and napsin-A. Immunostains for CK-20 and ALK were negative. These features were consistent with PA-SRC. It has been reported that approximately 70% of PAs demonstrate ALK gene rearrangement when SRCs comprised >10% of the tumor cells. The presence of SRCs can be indicative of a lung primary and, because of frequent ALK gene rearrangement in PA-SRC, proper recognition of PA-SRC may be important in determining whether further testing is advisable (e.g., ALK immunostaining and/or ALK gene rearrangement).

Entities:  

Keywords:  Anaplastic lymphoma kinase; leptomeningeal carcinomatosis; pulmonary adenocarcinoma; signet ring cell

Mesh:

Substances:

Year:  2012        PMID: 23119115      PMCID: PMC3484500     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Cytomorphology of primary signet ring-cell carcinoma of the lung.

Authors:  Ni Jin; Chris Nguyen; Sania Shuja; Raafat Makary; David Wolfson
Journal:  Diagn Cytopathol       Date:  2009-02       Impact factor: 1.582

2.  Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.

Authors:  S H Merchant; M B Amin; P Tamboli; J Ro; N G Ordóñez; A G Ayala; B A Czerniak; J Y Ro
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

3.  Leptomeningeal metastases in the MRI era.

Authors:  J L Clarke; H R Perez; L M Jacks; K S Panageas; L M Deangelis
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 4.  Leptomeningeal carcinomatosis.

Authors:  S A Grossman; M J Krabak
Journal:  Cancer Treat Rev       Date:  1999-04       Impact factor: 12.111

5.  Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites.

Authors:  J K Kish; J Y Ro; A G Ayala; M J McMurtrey
Journal:  Hum Pathol       Date:  1989-11       Impact factor: 3.466

6.  Rare subtypes of adenocarcinoma of the lung.

Authors:  Sai-Hong Ignatius Ou; Tomoya Kawaguchi; Ross A Soo; Masanori Kitaichi
Journal:  Expert Rev Anticancer Ther       Date:  2011-10       Impact factor: 4.512

7.  Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.

Authors:  Sai-Hong Ignatius Ou; Argyrios Ziogas; Jason A Zell
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

8.  ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.

Authors:  Benjamin Solomon; Marileila Varella-Garcia; D Ross Camidge
Journal:  J Thorac Oncol       Date:  2009-12       Impact factor: 15.609

9.  Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

Authors:  Scott J Rodig; Mari Mino-Kenudson; Sanja Dacic; Beow Y Yeap; Alice Shaw; Justine A Barletta; Hannah Stubbs; Kenny Law; Neal Lindeman; Eugene Mark; Pasi A Janne; Thomas Lynch; Bruce E Johnson; A John Iafrate; Lucian R Chirieac
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

10.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

View more
  3 in total

1.  An Unusual Presentation of Isolated Leptomeningeal Disease in Carcinoma of Unknown Primary With Pancreatic Features.

Authors:  Madhurima Anne; Nazish Ahmad; Paul Lee; Mohamed Aziz; Yehuda Lebowicz
Journal:  J Investig Med High Impact Case Rep       Date:  2013-06-18

2.  Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.

Authors:  Mingxia Shi; Hongzhi Xu; Angela DiPoto Brahmbhatt; Eduardo Gonzalez-Toledo; Maria-Magdalena Georgescu
Journal:  Am J Case Rep       Date:  2018-01-26

3.  ALK-positive pulmonary adenocarcinoma with signet ring features (PASRF) and polygonal cell morphology simultaneously co-expressing TTF-1/p63/P40: a case report.

Authors:  Yang Tan; Xiaofang Lu; Yun Li; Dingzhun Liao; Wenlin Xie; Jian Song; Ling Xue; Junfeng Zhu
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.